Profile data is unavailable for this security.
About the company
Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. The Company is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as advancing other pipeline assets. CBO421 is a development candidate targeting CD73 for the treatment of solid tumors. Its advanced DFC program is CD388, a highly potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase I and Phase IIa clinical trials. Its additional programs target multiple autoimmune indications.
- Revenue in USD (TTM)63.91m
- Net income in USD-22.93m
- Incorporated2012
- Employees69.00
- LocationCidara Therapeutics Inc6310 Nancy Ridge Dr Ste 101SAN DIEGO 92121-3209United StatesUSA
- Phone+1 (858) 752-6170
- Fax+1 (302) 655-5049
- Websitehttps://www.cidara.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equillium Inc | 36.08m | -13.34m | 51.47m | 44.00 | -- | 2.28 | -- | 1.43 | -0.3845 | -0.3845 | 1.04 | 0.6403 | 0.5597 | -- | 10.98 | 820,090.90 | -20.68 | -46.81 | -38.46 | -57.36 | -- | -- | -36.96 | -328.35 | -- | -- | 0.00 | -- | 128.97 | -- | 78.64 | -- | 7.48 | -- |
| Hcw Biologics Inc | 2.84m | -24.99m | 52.08m | 45.00 | -- | 3.68 | -- | 18.32 | -0.6953 | -0.6953 | 0.0791 | 0.3737 | 0.0755 | -- | 2.91 | 63,150.89 | -66.37 | -- | -78.58 | -- | 19.72 | -- | -879.53 | -- | -- | -90.86 | 0.319 | -- | -57.72 | -- | -67.74 | -- | -- | -- |
| Ocean Biomedical Holdings Inc | 0.00 | -45.58m | 52.15m | 9.00 | -- | -- | -- | -- | -1.40 | -1.40 | 0.00 | -0.0642 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -612.50 | -- | -- | -- |
| Correlate Energy Corp | 7.56m | -12.79m | 52.16m | 19.00 | -- | -- | -- | 6.90 | -0.3554 | -0.3554 | 0.21 | -0.0877 | 2.22 | -- | 13.19 | 398,051.60 | -375.16 | -315.47 | -- | -- | 18.27 | 15.42 | -169.09 | -201.03 | -- | -0.7239 | 8.30 | -- | 122.20 | 46.12 | -78.54 | -- | -- | -- |
| Intensity Therapeutics Inc | 0.00 | -11.86m | 52.78m | 5.00 | -- | 4.01 | -- | -- | -0.8653 | -0.8653 | 0.00 | 0.9601 | 0.00 | -- | -- | 0.00 | -110.62 | -- | -254.70 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.45 | -- | -- | -- |
| China Health Industries Holdings, Inc. | 117.28k | -1.51m | 53.09m | 32.00 | -- | -- | -- | 452.65 | -0.023 | -0.023 | 0.0018 | -0.0349 | 0.0044 | 0.5692 | 25.25 | 3,665.00 | -5.72 | 3.04 | -7.60 | 3.66 | -2.37 | 69.55 | -1,287.13 | 28.61 | 0.0377 | -- | 1.68 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
| Enzo Biochem Inc | 32.80m | -23.31m | 53.27m | 179.00 | -- | 0.7419 | -- | 1.62 | -0.4699 | 0.6708 | 0.6586 | 1.40 | 0.3738 | 1.61 | 4.10 | 183,257.00 | -26.56 | -12.21 | -39.50 | -15.79 | 42.17 | 37.09 | -71.07 | -18.76 | 2.89 | -- | 0.0476 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| Gain Therapeutics Inc | 55.18k | -22.27m | 53.61m | 29.00 | -- | 3.83 | -- | 971.63 | -1.74 | -1.74 | 0.0042 | 0.7761 | 0.0026 | -- | 0.2544 | 1,902.76 | -104.28 | -- | -132.41 | -- | -- | -- | -40,354.33 | -13,827.07 | -- | -- | 0.0432 | -- | -60.62 | 21.77 | -26.59 | -- | 13.96 | -- |
| Cidara Therapeutics Inc | 63.91m | -22.93m | 53.87m | 69.00 | -- | -- | -- | 0.843 | -0.2528 | -0.2528 | 0.7136 | -0.0906 | 1.12 | -- | 5.79 | 926,159.40 | -40.05 | -65.23 | -804.74 | -154.37 | 45.03 | -- | -35.88 | -100.61 | 0.8122 | -- | -- | -- | -0.8425 | -- | 31.72 | -- | 23.33 | -- |
| Yubo International Biotech Ltd | 604.68k | -1.20m | 53.92m | 18.00 | -- | -- | -- | 89.17 | -0.01 | -0.01 | 0.005 | -0.0154 | 0.3012 | 0.6912 | 9.19 | 33,593.33 | -59.52 | -- | -- | -- | 69.32 | -- | -197.64 | -- | 0.1504 | -3,143.97 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
| Eagle Pharmaceuticals Inc | 257.55m | 11.95m | 54.42m | 134.00 | 4.60 | 0.2177 | 1.66 | 0.2113 | 0.911 | 0.911 | 19.59 | 19.25 | 0.6549 | 1.55 | 2.56 | 1,922,022.00 | 3.04 | 6.37 | 4.04 | 7.98 | 69.84 | 71.86 | 4.64 | 7.85 | 1.67 | 3.55 | 0.2178 | 0.00 | 84.56 | 5.99 | 513.14 | -8.42 | -49.05 | -- |
| Ikena Oncology Inc | 9.16m | -68.17m | 54.46m | 43.00 | -- | 0.3696 | -- | 5.94 | -1.63 | -1.63 | 0.2196 | 3.52 | 0.0503 | -- | -- | 213,046.50 | -37.42 | -29.72 | -41.48 | -34.62 | -- | -- | -744.09 | -294.90 | -- | -- | 0.00 | -- | -41.35 | 56.05 | 0.8711 | -- | 6.30 | -- |
| Avrobio Inc | 0.00 | 12.16m | 54.73m | 13.00 | 4.43 | 0.575 | 4.28 | -- | 0.2756 | 0.2756 | 0.00 | 2.12 | 0.00 | -- | -- | 0.00 | 11.86 | -45.22 | 13.10 | -49.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 111.48 | -- | -66.27 | -- |
| Clene Inc. | 654.00k | -49.50m | 56.13m | 82.00 | -- | 4.19 | -- | 85.82 | -0.5449 | -0.5449 | 0.0062 | 0.1043 | 0.0135 | 3.03 | 3.94 | 7,975.61 | -102.25 | -39.43 | -171.75 | -47.32 | 81.50 | -- | -7,569.42 | -5,261.20 | 1.53 | -30.88 | 0.6659 | -- | 38.27 | -- | -65.47 | -- | -- | -- |
| Eledon Pharmaceuticals Inc | 0.00 | -40.33m | 56.82m | 20.00 | -- | 0.6647 | -- | -- | -1.82 | -1.82 | 0.00 | 3.45 | 0.00 | -- | -- | 0.00 | -44.35 | -38.44 | -47.03 | -39.80 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 54.16 | -- | -- | -- |
Data as of May 01 2024. Currency figures normalised to Cidara Therapeutics Inc's reporting currency: US Dollar USD
